Grants Portfolio - Active Awards

AFTD-ADDF Accelerating Drug Discovery for FTD

AH FBLI - Rothstein AFTD-ADDF Award - 1

Mitigating TDP-43 loss of function and disease initiation in FTD thru repair of the Nuclear Pore and CHMP7/ESCRT3 dysfunction

Jeffrey Rothstein, MD, PhD  | Johns Hopkins School of Medicine
2023
$269,967

martinez

TTBK1 inhibitors as new therapeutic approach for FTD and other related disorders

Ana Martinez, PhD | Ankar Pharmaceuticals 
2022
$185,000

Robert Willliams

Selecting lead candidate REV-ERB agonist for the treatment of FTD

Robert Williams, PhD | Pelagos Pharmaceuticals
2022
$214,118

Kenneth Kosik

Discovery of selective LRP1 inhibitors to prevent tau uptake and spread

Kenneth Kosik, MD  |  University of California Santa Barbara
2020
$300,000

Wen-Hsuan Chang, PhD

Development of PIKFYVE antisense oligonucleotides (ASO) treatment for FTD

Wen-Hsuan Chang, PhD  |  AcuraStem Inc.
2020
$165,000

Dieter Edbauer, MD

Preclinical efficacy study for antibody therapy in C9orf72 FTD/ALS mice 

Dieter Edbauer, MD  | Deutschen Zentrums für Neurodegenerative Erkrankungen DZNE
2019
$300,000

AFTD-ADDF Diagnostics Accelerator

Khillan-square

Neurofilament (Nf) as a Fluid Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (f-FTD)

Rohini Khillan, PhD  | Foundation for the National Institutes of Health (FNIH)
2021
$250,000

Q Mao

Plasma pathologic TDP-43 as a biomarker for FTLD-TDP

Qinwen Mao, MD, PhD  | The University of Utah School of Medicine
2021
$500,000

Pase - square

Plasma neuroinflammatory biomarkers for the diagnosis of dementia subtypes

Matthew Pase  |  Monash University
2021
$671,160

Rodney Pearlman, PhD-01

Remote blood biomarker monitoring in frontotemporal lobar degeneration: Neurofilament Surveillance Project (NSP)

Rodney Pearlman, PhD  |  The Bluefield Project to Cure FTD
October 2019
$1,200,000

FTD Biomarkers Initiative

Lashley Tammaryn

Mapping neuroinflammation in frontotemporal lobar degeneration – development of a surrogate marker for early diagnosis and disease progression

Tammaryn Lashley, MD, PhD  | UCL Institute of Neurology
2019
$1,102,133.19

Lashley Tammaryn

Accelerating tau PET imaging through head to head comparison of novel radiotracers

Tammaryn Lashley, MD, PhD  | UCL Institute of Neurology
2018
$247,272

Digital Assessment Tools for FTD and ALS

adam_staffaroni_aftdeduconf

Harmonizing remote smartphone assessments of cognition, behavior, and motor functioning across the spectrum of FTD and ALS

Adam Staffaroni, PhD |  UCSF
2023
$350,000

Ashkan Vaziri Headshot

Digital Measurements of Motor and Voice Functions in FTD

Ashkan Vaziri, PhD | BioSensics
2023
$399,999

Target ALS Partnership

Shorter - square

Identification of Small Molecule Inhibitors of TDP-43 Liquid-Liquid Phase Separation

James Shorter, PhD |  Merck
2016
$850,000

Cheneval - Square

Targeting G3BP1 and the stress granule response as a therapy for ALS & FTD

Dominique Cheneval, PhD  | Novation Pharmaceuticals
2020
$723,175

Treat FTD Fund

Dr. Simon Ducharme 041323

Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia

Simon Ducharme, MD  |  McGill University
2021
$1,399,077.51

Paul Edison

Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)

Paul Edison, MD  |  Imperial College London
2021
$3,000,000

Giacomo-Koch-01

Dopaminergic Therapy for Frontotemporal Dementia Patients

Giacomo Koch, PhD  |  Saint Lucia Foundation
2020
$602,800

Emiliano Santarnecchi, PhD-01

Non-Invasive Brain Stimulation for Gamma Induction and Cognitive Enhancement in FTD

Emiliano Santarnecchi, PhD  |  Harvard Medical School
2019
$1,959,841

Borroni - Square

Non-invasive brain stimulation to restore cortical plasticity

Barbara Borroni, MD | University of Brescia
2017
$90,000

Pilot Grants

McEachin - Square

PATHWAYS OF HOPE

Integrated proteomics and phosphoproteomics across FTLD-TDP subtypes

Zachary McEachin | Emory University
2023
$110,000

Melamed - square

PATHWAYS OF HOPE

Synthetic promoter screening to uncover determinants of FTD pathology

Zevik Melamed | Hebrew University of Jerusalem
2023
$110,000

Bunnik - Square

WELL-BEING IN FTD

An ethical framework for disclosure of onset-predicting biomarkers in frontotemporal dementia

Eline Bunnik, PhD | Erasmus Medical Center
2023
$110,000

Iordan - left - and postdoc

WELL-BEING IN FTD

Social Network Neuromodulation in Behavioral Variant Frontotemporal Dementia

Alexandru Iordan, PhD | University of Michigan
2022
$109,784

Alinka Fisher

WELL-BEING IN FTD

Positive Behaviour Support (PBS) for individuals with frontotemporal dementia: increasing service and family capacity through a mentoring and training model

Alinka Fisher, PhD  |  Finders University
2021
$58,616

ISFTD Infrastructure Grant

JvS - square

John van Swieten, PhD | International Society for Frontotemporal Dementias (ISFTD)
2023
$250,000

Clinical Research Training Scholarship in FTD

Saloner - Square

Large-scale biofluid proteomics to identify disease progression biomarkers in C9orf72 frontotemporal dementia

Rowan Saloner, PhD | UCSF
2024
$150,000

Tanav Popli - Indiana University

Personalized HD-tDCS in Primary Progressive Aphasia

Tanav Popli, MD | University of Michigan
2023
$150,000

Indira Garcia Cordero, PhD

Multimodal evidence of the role of Alzheimer’s disease pathology in corticobasal and progressive supranuclear palsy syndromes

Indira García Cordero, PhD  | University of Toronto
2022
$150,000

Holloway Postdoctoral Fellowships

Replogle - Square

Determining the Impact of TMEM106B Fibrils on Neurons

John Replogle, PhD | National Institute of Neurological Disorders and Stroke (NIH/NINDS)
2024
$120,000

Victoria-Helmly

Frontotemporal Dementia (FTD) and the Criminal Legal System: An Examination of Experiences and Policies

Victoria Helmly, PhD | Georgia State University
2024
$120,000

MShenouda

Targeting TDP-43 aggregation as therapeutics for ALS/FTD

Marc Shenouda, PhD | University of Toronto
2023
$120,000

poos

Virtual Reality Social Cognition Game for Preclinical Frontotemporal Dementia

Jackie Poos  | Erasmus Medical Center
July 2023
$115,123

Suborno Jati, PhD

Deciphering the consequence of ChromograninA (CgA) depletion in Tauopathy

Suborno Jati, PhD  | Regents of the University of California
2022
$120,000 

Julia Faura Llorens, PhD

Long-read transcriptomics in FTLD-TDP to aid in the identification of novel biomarkers and mechanistic insights

Julia Faura Llorens, PhD  | University of Antwerp
2022
$119,947